Fingerprint
Dive into the research topics of 'Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: A trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically